Moderna in talks with U.S. regulators to expand COVID-19 vaccine pediatric study

Moderna is in talks with U.S. regulators to expand the size of an ongoing trial testing its COVID-19 vaccines in children aged between 5 and 11, the drugmaker said on Monday.